Alpha Teknova (NASDAQ:TKNO) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Alpha Teknova (NASDAQ:TKNO) posted its quarterly earnings results on Tuesday. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.03, Yahoo Finance reports. Alpha Teknova had a negative net margin of 97.85% and a negative return on equity of 38.24%. The firm had revenue of $9.61 million for the quarter, compared to analyst estimates of $9.50 million. During the same quarter in the previous year, the business posted ($0.25) earnings per share.

Alpha Teknova Stock Up 4.6 %

Shares of Alpha Teknova stock traded up $0.17 during midday trading on Thursday, reaching $3.88. 121,161 shares of the company’s stock traded hands, compared to its average volume of 228,816. The company has a market cap of $158.39 million, a price-to-earnings ratio of -3.81 and a beta of 0.39. Alpha Teknova has a 52 week low of $1.15 and a 52 week high of $4.39. The company’s 50 day simple moving average is $2.26 and its 200 day simple moving average is $2.41. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.92 and a current ratio of 5.52.

Insider Buying and Selling

In related news, CFO Matthew Lowell purchased 40,322 shares of the firm’s stock in a transaction dated Friday, July 12th. The stock was bought at an average price of $1.24 per share, for a total transaction of $49,999.28. Following the purchase, the chief financial officer now owns 128,376 shares in the company, valued at approximately $159,186.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Alpha Teknova news, major shareholder Telegraph Hill Partners Iv, L. purchased 12,096,773 shares of the company’s stock in a transaction on Friday, July 12th. The shares were bought at an average cost of $1.24 per share, with a total value of $14,999,998.52. Following the transaction, the insider now directly owns 11,126,929 shares in the company, valued at approximately $13,797,391.96. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Matthew Lowell purchased 40,322 shares of the company’s stock in a transaction on Friday, July 12th. The stock was acquired at an average cost of $1.24 per share, for a total transaction of $49,999.28. Following the completion of the transaction, the chief financial officer now owns 128,376 shares in the company, valued at $159,186.24. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 12,217,740 shares of company stock worth $15,149,998. Corporate insiders own 15.20% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Stephens restated an “overweight” rating and set a $5.00 price objective on shares of Alpha Teknova in a report on Wednesday, July 10th.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.